US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

154.90

+15.3811.02%

Post-market: 154.14-0.7600-0.49%19:59 EDT

Volume:687.47K

Turnover:105.67M

Market Cap:530.45M

PE:- -

High:158.50

Open:145.43

Low:145.43

Close:139.52

52wk High:198.18

52wk Low:32.55

Shares:3.42M

Float Shares:3.27M

Volume Ratio:0.93

T/O Rate:20.99%

Dividend:1.34

Dividend Rate:0.87%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

ETF & Stock Investment+0.64%

Fractional Shares+0.64%

Capital Flow

Inflow:

Outflow:

News

Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction

Atomo Diagnostics Halts Trading Ahead of Key FDA Decision on FebriDx

Bio-Gene Showcases Nature-Derived Insecticide Strategy at 2026 NWR Healthcare Conference

Press Release: Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LABU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":154.9,"timestamp":1774468800000,"preClose":139.52,"halted":0,"volume":687472,"hourTrading":{"tag":"盘后","latestPrice":154.14,"preClose":154.9,"latestTime":"19:59 EDT","volume":3079,"amount":476376.2679,"timestamp":1774483172682,"change":-0.76,"changeRate":-0.004906,"amplitude":0.00581},"delay":0,"changeRate":0.11023509174311923,"floatShares":3274486,"shares":3424486,"eps":0,"marketStatus":"Not Yet Opened","change":15.38,"latestTime":"03-25 16:00:00 EDT","open":145.43,"high":158.5022,"low":145.43,"amount":105671871.0976,"amplitude":0.093694,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":139.52,"sharesOutstanding":3074486,"nav":139.556,"aum":470929648.23,"dividendRate":0.008674,"bidAskSpread":0.003772,"preHourTrading":{"tag":"盘前","latestPrice":145,"preClose":139.52,"latestTime":"09:29 EDT","volume":8074,"amount":1168934.82684,"timestamp":1774445385104,"change":5.48,"changeRate":0.039278,"amplitude":0.032253},"postHourTrading":{"tag":"盘后","latestPrice":154.14,"preClose":154.9,"latestTime":"19:59 EDT","volume":3079,"amount":476376.2679,"timestamp":1774483172682,"change":-0.76,"changeRate":-0.004906,"amplitude":0.00581},"volumeRatio":0.926788,"impliedVol":1.0072,"impliedVolPercentile":0.7968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.926788,"shares":3424486,"dividePrice":1.3436,"high":158.5022,"amplitude":0.093694,"preClose":139.52,"low":145.43,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":154.9,"eps":0,"divideRate":0.008674,"volume":687472,"delay":0,"ttmEps":0,"open":145.43,"prevYearClose":159.39,"prevWeekClose":142.74,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":146.14,"twentyDayClose":176.87,"sixtyDayClose":171.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622843778","title":"Royal Healthcare in Singapore provides NEC's \"FonesVisuas Test\" for Disease Risk Prediction","url":"https://stock-news.laohu8.com/highlight/detail?id=2622843778","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622843778?lang=en_us&edition=fundamental","pubTime":"2026-03-26 10:00","pubTimestamp":1774490400,"startTime":"0","endTime":"0","summary":"TOKYO, March 26, 2026 /PRNewswire/ --NEC Corporation  announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise with the art of hospitality.According to the World Health Organization , the global rise in lifestyle-related diseases and dementia underscores the urgency for advanced predictive diagnostics (*2). Concurrently, theOrganisation for Economic Co-operation and Development  iLibrary data has identified cancer and cardiovascular diseases as leading causes of mortality worldwide (*3), amplifying the urgency for proactive health management solutions.Royal Healthcare is based in Singapore's medical hub, Novena, providing personalized, high-quality health screening services alongside customized medical experiences that prioritize efficiency and convenience for both local and international pat","market":"other","thumbnail":"https://mma.prnewswire.com/media/2941958/Entrance_of_the_Specialist_Medical_Centre.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2941958/Entrance_of_the_Specialist_Medical_Centre.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/royal-healthcare-in-singapore-provides-necs-fonesvisuas-test-for-disease-risk-prediction-302724608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4017","HCSG","RGLD","LU0029874061.USD","XBI","BK4137","XLV","BK4581","LU0128526141.USD","LU0345780521.USD","BK4585","LU0345780281.USD","BK4588","LABU"],"gpt_icon":0},{"id":"2622884332","title":"Atomo Diagnostics Halts Trading Ahead of Key FDA Decision on FebriDx","url":"https://stock-news.laohu8.com/highlight/detail?id=2622884332","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622884332?lang=en_us&edition=fundamental","pubTime":"2026-03-26 09:48","pubTimestamp":1774489699,"startTime":"0","endTime":"0","summary":"An announcement from Atomo Diagnostics Ltd. ( ($AU:AT1) ) is now available. Atomo Diagnostics has requested a trading halt on its ASX-listed securi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atomo-diagnostics-halts-trading-ahead-of-key-fda-decision-on-febridx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atomo-diagnostics-halts-trading-ahead-of-key-fda-decision-on-febridx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"gpt_icon":0},{"id":"2622881654","title":"Bio-Gene Showcases Nature-Derived Insecticide Strategy at 2026 NWR Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2622881654","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622881654?lang=en_us&edition=fundamental","pubTime":"2026-03-26 09:37","pubTimestamp":1774489039,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd. ( ($AU:BGT) ) has provided an update. Bio-Gene Technology used the NWR Virtual Healthcare Conference 2026 to showcase its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bio-gene-showcases-nature-derived-insecticide-strategy-at-2026-nwr-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bio-gene-showcases-nature-derived-insecticide-strategy-at-2026-nwr-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","HCSG","XBI","XLV","BK4137","BK4588","LABU","LU0128526141.USD","LU0029874061.USD"],"gpt_icon":0},{"id":"2622888069","title":"Press Release: Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622888069","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622888069?lang=en_us&edition=fundamental","pubTime":"2026-03-26 07:00","pubTimestamp":1774479600,"startTime":"0","endTime":"0","summary":"-- Product sales and commercial rights revenues in 2025 increased 90%. -- Sales of Olverembatinib increased 81% year-over-year to US$62.2 million. -- Sales of Lisaftoclax since launch during last five months of 2025 were. Dr. Dajun Yang, Chairman and Chief Executive Officer of Ascentage Pharma, said, \"2025 was a year of significant execution in advancing our mission to deliver innovative therapies to patients worldwide. We advanced our commercialization strategy as Olverembatinib gained significant traction after receiving NRDL coverage expansion, which has markedly enhanced affordability and accessibility for patients in China. We launched Lisaftoclax in China in late July 2025 shortly after receiving regulatory approval and are gaining market adoption as we actively pursue the inclusion of Lisaftoclax in China's NRDL.\". Olverembatinib  is a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI approved in China for treatment of patients with chronic myeloid leukemia ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4181","BK4585","BK4588","BK1574","BK4218","BK6008","PK","BK4081","LU1223082519.USD","LU1223083913.SGD","BK4017","LU1223082196.USD","EMA","06855","5BI.SI","BK6514","LABU","AAPG","CDE","BK1161"],"gpt_icon":0}],"pageSize":4,"totalPage":110,"pageCount":1,"totalSize":438,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LABU\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.006436},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.006435}]}}